391
|
|
|
TIMP metallopeptidase inhibitor 1 |
CLGI, EPA, EPO, HCI, TIMP, TIMP-1 |
Ankylosing spondylitis, Aortic valve disease, Autoimmune disease, Calcinosis, Cholangitis, Cholelithiasis, Experimental diabetes, Diabetes mellitus type 2, Female infertility, Heart disease, Heart valve disease, Heart valve prolapse, Hepatolenticular degeneration, Hypertension, Iga nephropathy, Liver cirrhosis, Oral submucous fibrosis, Pulmonary fibrosis, Rheumatic aortic regurgitation, Varicose veins, Vascular diseaseView all (6 more) |
392
|
|
|
TIMP metallopeptidase inhibitor 2 |
CSC-21K, DDC8 |
Alzheimer disease, Calcinosis, Central nervous system cancer, Cholelithiasis, Coronary artery disease, Experimental diabetes, Diverticular disease, Dupuytren contracture, Eosinophilia, Glioblastoma, Glioma, Liver cirrhosis, Moyamoya disease, Myocardial infarction, Obesity, Occupational disease, Periodontitis, Pleural diseases, Respiratory system disease, Urinary bladder neoplasmsView all (5 more) |
393
|
|
|
TIMP metallopeptidase inhibitor 3 |
HSMRK222, K222, K222TA2, SFD |
|
394
|
|
|
TIMP metallopeptidase inhibitor 4 |
TIMP-4 |
|
395
|
|
|
Tubulointerstitial nephritis antigen |
TIN-AG |
|
396
|
|
|
Tubulointerstitial nephritis antigen like 1 |
ARG1, LCN7, LIECG3, TINAGRP |
|
397
|
|
|
TINCR ubiquitin domain containing |
LINC00036, NCRNA00036, PLAC2, TUBL, onco-lncRNA-16 |
|
398
|
|
|
TERF1 interacting nuclear factor 2 |
DKCA3, DKCA5, TIN2 |
|
399
|
|
|
TCDD inducible poly(ADP-ribose) polymerase |
ARTD14, PARP7, pART14 |
|
400
|
|
|
TIMELESS interacting protein |
- |
|
